SCHEMBL166815

SCHEMBL166815

O=C(CN1CNc2ccccc21)N1CCN(c2ccccc2-c2ccccc2)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR3 P49682 2/20 0.57
KCNH2 Q12809 1/20 0.57
DPP4 P27487 1/20 0.46
HTR1A P08908 5/20 0.45
DRD2 P14416 4/20 0.45
HTR7 P34969 2/20 0.44
HTR2A P28223 1/20 0.44
HTR5A P47898 1/20 0.44
HTR6 P50406 1/20 0.44
MAPT P10636 3/20 0.43
TP53 P04637 1/20 0.43
MEN1 O00255 1/20 0.43
GAA P10253 1/20 0.43
KMT2A Q03164 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 1/20 0.41
USP2 O75604 1/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3732700 0.79 CXCR3 (0.58) CXCR3KCNH2DPP4HTR1ADRD2
SCHEMBL3732864 0.77 KMT2A (0.71) CXCR3KCNH2DPP4MAPTMEN1
SCHEMBL3735517 0.77 ALDH1A1 (0.64) CXCR3KCNH2DPP4HTR1ADRD2
SCHEMBL31285850 0.75 KMT2A (0.42) MAPTMEN1GAAKMT2ASMN1; SMN2
SCHEMBL8793695 0.75 KMT2A (0.42) MAPTMEN1GAAKMT2ASMN1; SMN2
SCHEMBL5238054 0.74 HTR1A (0.57) CXCR3KCNH2DPP4HTR1ADRD2
SCHEMBL112559 0.73 CXCR3 (1.00) CXCR3KCNH2DPP4HTR1ADRD2
SCHEMBL3732859 0.72 CXCR3 (0.52) CXCR3KCNH2DPP4HTR1ADRD2
SCHEMBL3736567 0.72 CXCR3 (0.52) CXCR3KCNH2DPP4HTR1AHTR7
SCHEMBL13039596 0.71 CXCR3 (0.68) CXCR3KCNH2DPP4HTR1ADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424840-A1 CXCR3 RECEPTOR ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-03-07 EP disclosed
WO-2010126811-A1 CXCR3 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-11-04 WO disclosed